Breaking News Instant updates and real-time market news.

FPRX

Five Prime

$53.43

-6.02 (-10.13%)

07:55
12/08/16
12/08
07:55
12/08/16
07:55

Five Prime to host research and development day

Research and Development Day to be held in New York on December 8 at 8 am. Webcast Link

  • 08

    Dec

  • 14

    Dec

FPRX Five Prime
$53.43

-6.02 (-10.13%)

01/21/16
01/21/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3M (MMM) initiated with a Buy at Citi... AMAG Pharmaceuticals (AMAG) initiated with an Equal Weight at Barclays... Acceleron (XLRN) initiated with an Outperform at Credit Suisse... Agios Pharmaceuticals (AGIO) initiated with an Outperform at Credit Suisse... Akebia (AKBA) initiated with a Neutral at Credit Suisse... CIT Group (CIT) initiated with a Hold at Deutsche Bank... Check Point (CHKP) initiated with a Neutral at Cleveland Research... Clovis (CLVS) initiated with an Outperform at Credit Suisse... Colfax (CFX) initiated with a Sell at Citi... Danaher (DHR) initiated with a Neutral at Citi... Dover (DOV) initiated with a Neutral at Citi... Emerson (EMR) initiated with a Sell at Citi... Endo (ENDP) initiated with an Equal Weight at Barclays... Endocyte (ECYT) initiated with an Outperform at Credit Suisse... FibroGen (FGEN) initiated with a Neutral at Credit Suisse... FireEye (FEYE) initiated with an Outperform at Northland... Five Prime (FPRX) initiated with an Outperform at Credit Suisse... Flowserve (FLS) initiated with a Neutral at Citi... General Electric (GE) initiated with a Buy at Citi... Honeywell (HON) initiated with a Buy at Citi... Ignyta (RXDX) initiated with an Outperform at Credit Suisse... Illinois Tool Works (ITW) initiated with a Buy at Citi... Imperva (IMPV) initiated with an Outperform at Northland... Ingersoll-Rand (IR) initiated with a Buy at Citi... Joint Corp. (JYNT) initiated with a Buy at Maxim... M&T Bank (MTB) resumed with a Neutral at JPMorgan... Medivation (MDVN) initiated with an Outperform at Credit Suisse... Newfield Exploration (NFX) initiated with an Outperform at Imperial Capital... OvaScience (OVAS) initiated with an Underperform at Credit Suisse... PFSweb (PFSW) initiated with a Buy at Canaccord... Palo Alto (PANW) initiated with an Outperform at Northland... Perrigo (PRGO) initiated with an Overweight at Barclays... Prothena (PRTA) initiated with an Outperform at Credit Suisse... Puma Biotechnology (PBYI) initiated with an Outperform at Credit Suisse... Rockwell Automation (ROK) initiated with a Neutral at Citi... Seattle Genetics (SGEN) initiated with an Outperform at Credit Suisse... Shopify (SHOP) initiated with an Outperform at Wedbush... Square (SQ) initiated with a Market Perform at William Blair... TESARO (TSRO) initiated with an Outperform at Wedbush... Tyco (TYC) initiated with a Neutral at Citi... Ultragenyx (RARE) initiated with an Outperform at Credit Suisse.
05/11/16
05/11/16
NO CHANGE

Leerink major pharma & biotech analyst holds analyst/industry conference call
Biotech Analyst Schmidt and Major Pharmaceuticals Analyst Fernandez, along with University of Chicago Departments of Pathology & Medicine, Professor Dr. Thomas F. Gajewski, discuss the tumor micro-environment on an Analyst/Industry conference call to be held on May 11 at 2 pm.
08/09/16
WELS
08/09/16
NO CHANGE
WELS
Five Prime weakness overdone, says Wells Fargo
After a trial of the OPDIVO cancer treatment of Five Prime's (FPRX) partner, Bristol Myers Squibb (BMY), showed disappointing results, Wells Fargo thinks that the nearly 9% decline in Five Prime's stock was overdone. The firm thinks that it's "premature" to determine that Merck's (MRK) Keytruda has overtaken OPDIVO. The firm believes that Five Prime's OPDIVO can redeem itself in upcoming studies, and it thinks that Five Prime's stock can advance if the actor-1 receptor is proven to be a worthwhile target ,whether or not OPDIVO is shown to be effective. The firm keeps an Outperform rating on Five Prime.
10/25/16
SBSH
10/25/16
INITIATION
Target $65
SBSH
Buy
Five Prime initiated with a Buy at Citi
Citi analyst Robyn Karnauskas started Five Prime Therapeutics with a Buy rating and $65 price target. The company has "multiple shots" on goal in various cancers, Karnauskas tells investors in a research note. She believes investors will assign higher value to the Cabiralizumab program once combo data with Opdivo is seen in 2017. The analyst sees fair value for Five Prime shares in the $65-$80 range.

TODAY'S FREE FLY STORIES

DLR

Digital Realty

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Initiation
Digital Realty initiated  »

Digital Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Options
Overnight activity included 125 trades in SPX and 21 trades in VIX »

125 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

09:17
09/22/17
09/22
09:17
09/22/17
09:17
Hot Stocks
Conagra Brands to acquire Angie's Artisan Treats, terms not disclosed »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Euro$ interest rate futures have continued to steady »

Euro$ interest rate…

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Breaking General news story  »

Kansas City Federal…

HDSN

Hudson Technologies

$8.47

-0.79 (-8.53%)

09:14
09/22/17
09/22
09:14
09/22/17
09:14
Recommendations
Hudson Technologies analyst commentary  »

Roth says Hudson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

ACN

Accenture

09:11
09/22/17
09/22
09:11
09/22/17
09:11
Recommendations
Accenture analyst commentary  »

Accenture risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

09:10
09/22/17
09/22
09:10
09/22/17
09:10
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

DKS

Dick's Sporting

$26.23

-0.31 (-1.17%)

09:05
09/22/17
09/22
09:05
09/22/17
09:05
Hot Stocks
Dick's Sporting to open four new stores in three states in September »

DICK'S Sporting Good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

, CETX

Cemtrex

$3.21

-0.09 (-2.73%)

09:04
09/22/17
09/22
09:04
09/22/17
09:04
Hot Stocks
Bharat Parikh & Associates responds to Key Tronic's allegations »

Bharat Parikh &…

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

CETX

Cemtrex

$3.21

-0.09 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:03
09/22/17
09/22
09:03
09/22/17
09:03
General news
Futures point to slightly lower open after new North Korean threats »

Futures are a bit lower…

PGTI

PGT, Inc.

$14.00

0.05 (0.36%)

09:02
09/22/17
09/22
09:02
09/22/17
09:02
Hot Stocks
PGT Innovations sells door glass processing assets for $28M »

PGT Innovations announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

PNM

PNM Resources

09:00
09/22/17
09/22
09:00
09/22/17
09:00
Initiation
PNM Resources initiated  »

PNM Resources initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

, M

Macy's

$21.16

-0.32 (-1.49%)

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Hot Stocks
Finish Line: Comps down 0.6% in June, down 9% in July, down 4.2% in August »

Finish Line (FINL) says…

FINL

Finish Line

$9.22

-0.21 (-2.23%)

M

Macy's

$21.16

-0.32 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

WBC

Wabco

$149.19

1.55 (1.05%)

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Conference/Events
Wabco holds a conference call »

Chairman & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Conference/Events
Federal Reserve Bank of Kansas City President to speak at conference »

Kansas City Federal…

08:50
09/22/17
09/22
08:50
09/22/17
08:50
General news
U.S. equities came back under the gun »

U.S. equities came back…

FINL

Finish Line

$9.22

-0.21 (-2.23%)

08:48
09/22/17
09/22
08:48
09/22/17
08:48
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line: Store visits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

CBI

CB&I

$16.26

0.26 (1.63%)

, AAOI

Applied Optoelectronics

$63.60

-0.36 (-0.56%)

08:45
09/22/17
09/22
08:45
09/22/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

CBI

CB&I

$16.26

0.26 (1.63%)

AAOI

Applied Optoelectronics

$63.60

-0.36 (-0.56%)

S

Sprint

RSX

Market Vectors Russia ETF

$21.80

0.05 (0.23%)

SHLD

Sears

$7.05

-0.16 (-2.22%)

XBI

SPDR S&P BIOTECH

$84.59

-0.58 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 02

    Oct

  • 16

    Nov

  • 16

    May

08:45
09/22/17
09/22
08:45
09/22/17
08:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CPST

Capstone Turbine

$0.64

0.002 (0.31%)

08:44
09/22/17
09/22
08:44
09/22/17
08:44
Hot Stocks
Capstone microturbines continue to power though Hurricanes Harvey, Irma, Maria »

Capstone Turbine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZRE

Azure Power

$15.61

0.4573 (3.02%)

08:43
09/22/17
09/22
08:43
09/22/17
08:43
Hot Stocks
Azure Power commissions 50 MW NTPC solar project in Uttar Pradesh »

Azure Power has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

VNRX

VolitionRx

$2.68

-0.04 (-1.47%)

08:43
09/22/17
09/22
08:43
09/22/17
08:43
Hot Stocks
VolitionRx announces initial sale of new Nu.Q research kits »

VolitionRx announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

EDGW

Edgewater

$6.57

-0.03 (-0.45%)

08:41
09/22/17
09/22
08:41
09/22/17
08:41
Hot Stocks
Edgewater extends stock repurchase program to September 21, 2018 »

Edgewater Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FINL

Finish Line

$9.22

-0.21 (-2.23%)

08:41
09/22/17
09/22
08:41
09/22/17
08:41
Hot Stocks
Finish Line sees sales, margin trends to remain 'difficult' for rest of year »

Finish Line says Q2 was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.